Lobe Sciences Ltd

Lobe Sciences Ltd

0.04
USD
+0.00
(+10.81%)
-0.02EPS
23.44MMarket Cap

Total Valuation

USD

As of May 31, 2026, LOBE SCIENCES LTD. carries a market capitalization of 23.44M, placing it among publicly traded companies globally. Its enterprise value stands at 20.86M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap23.44M
Enterprise Value20.86M

Share Statistics

As of May 31, 2026, LOBE SCIENCES LTD. has 308.18M shares outstanding.

Shares Outstanding308.18M

Valuation Ratios

These figures are as of May 31, 2026.

PB Ratio17.14
P/TBV Ratio17.14
P/FCF Ratio-7.26
P/OCF Ratio-7.26

Financial Position

As of May 31, 2026, LOBE SCIENCES LTD. maintains a current ratio of 2.38, meaning it holds 2.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 10.56, indicating elevated leverage, while an interest coverage ratio of -26.46 demonstrates limited ability to service its debt obligations.

Current Ratio2.38
Quick Ratio2.24
Debt / Equity10.56
Debt / EBITDA-0.05
Interest Coverage-26.46

Financial Efficiency

These figures cover the twelve months ended May 31, 2026. Return on assets (ROA) is negative at -85.26, reflecting losses generated across the asset base.

Return on Assets (ROA)-85.26

Stock Price Statistics

USD

As of the close on November 16, 2026, LOBE SCIENCES LTD.'s stock has gained approximately 18.20% over the past 52 weeks. The 50-day moving average sits at 0.04, while the 200-day moving average is 0.06.

52-Week Price Change18.20%
50-Day Moving Average0.04
200-Day Moving Average0.06

Income Statement

USD

Over the twelve months ended May 31, 2026, LOBE SCIENCES LTD. generated - - in revenue and converted that into -4.19M in net income, yielding earnings per share of -0.02. EBITDA reached -4.81M, while operating income came in at -4.97M.

Operating Income-4.97M
Pretax Income-5.12M
Net Income-4.19M
EBITDA-4.81M
EBIT-4.81M
Earnings Per Share (EPS)-0.02

Balance Sheet

USD

As of May 31, 2026, LOBE SCIENCES LTD. holds 3.78M in cash and equivalents against 245,342.57 in total debt, resulting in a net debt position of -845,945.77. Total book value stands at 1.37M, with working capital of 2.32M providing operational flexibility.

Cash & Cash Equivalents3.78M
Total Debt245,342.57
Net Debt-845,945.77
Equity (Book Value)1.37M
Working Capital2.32M

Cash Flow

USD

LOBE SCIENCES LTD. produced -2.71M in operating cash flow over the twelve months ended May 31, 2026.

Operating Cash Flow-2.71M
Free Cash Flow-2.71M
FCF Per Share-0.01

Dividends & Yields

These figures cover the twelve months ended May 31, 2026. Free cash flow yield is negative at -13.77: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -3.11, meaning LOBE SCIENCES LTD. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-3.11
FCF Yield-13.77

Stock Splits

LOBE SCIENCES LTD.'s most recent stock split took place on June 10, 2022 with a 6:1 split ratio.

Last Split Date6/10/2022
Split Ratio6:1

Scores

As of May 31, 2026, LOBE SCIENCES LTD. has an Altman Z-Score of -5.92, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-5.92